+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

What is the role of recombinant colony stimulating factors in bone marrow transplantation?



What is the role of recombinant colony stimulating factors in bone marrow transplantation?



Bone Marrow Transplantation 6(2): 79-87



Colony stimulating factors (CSFs) regulate production of myeloid cells. Use of CSFs post bone marrow transplant accelerates granulocyte recovery by shortening the interval of relative but not absolute granulocytopenia. Data from non-randomized trials suggest that CSFs decrease documented infections by about one-third; there is no apparent increase in survival. Adverse effects of CSFs are modest; there are no indications of increased graft failure, graft-versus-host disease or cancer recurrence after their use. Future studies of CSFs should be in the context of randomized trials where their therapeutic efficacy is best evaluated. CSFs may also be useful in other transplant settings such as treating graft failure or increasing the efficiency of harvesting myeloid progenitor cells from the blood for subsequent transplantation. Controlled trials are needed to evaluate these uses. Future directions will probably include combinations of CSFs and, possibly, in vitro treatment of the graft.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008005120

Download citation: RISBibTeXText

PMID: 2207455


Related references

Role of colony-stimulating factors in bone marrow transplantation. Seminars in Oncology 19(3 Suppl 7): 27-31, 1992

The role of colony-stimulating factors in bone marrow transplantation. Cancer Investigation 9(2): 221-228, 1991

The effect of recombinant human colony-stimulating factors on hematopoietic reconstitution following autologous bone marrow transplantation. Seminars in Hematology 26(2 Suppl 2): 18-23, 1989

Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF. Behring Institute Mitteilungen 1988(83): 289-300, 1988

Does recombinant granulocyte macrophage colony stimulating factor gm csf play a crucial role in the pathogenesis of atopic dermatitis after bone marrow transplantation bmt. Medical Science Research 19(12): 395, 1991

Recombinant granulocyte-macrophage colony stimulating factor and low dose recombinant human erythropoietin in bone marrow transplantation. Blood 86(10 Suppl. 1): 971A, 1995

Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation. Leukemia Research 15(12): 1175-1182, 1991

Recombinant granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for relapsed non hodgkin's lymphoma blood and bone marrow progenitor growth studies a phase ii eastern cooperative oncology group trial. Blood 78(3): 830-837, 1991

Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Experimental Hematology 17(10): 1047-1050, 1989

Recombinant human granulocyte colony stimulating factor for allogeneic bone marrow transplantation. Proceedings of the American Association for Cancer Research Annual Meeting 31: 173, 1990

Recombinant human granulocyte macrophage colony stimulating factor after bone marrow transplantation. Bone Marrow Transplantation 3(Suppl. 1): 92, 1988

Recombinant human granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Chinese Medical Journal 109(11): 827-831, 1996

Clinical application of recombinant human colony-stimulating factor (rhG-CSF) in bone marrow transplantation. Japanese Journal of Clinical Hematology 31(5): 589-596, 1990

Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation. Behring Institute Mitteilungen 1988(83): 313-319, 1988